NCT06052852 Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT06028594 Compassionate Use of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Status NO_LONGER_AVAILABLE Phase N/A
NCT06024408 A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor Status COMPLETED Phase PHASE1
NCT06019481 A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations Status WITHDRAWN Phase N/A
NCT06012448 The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction Status COMPLETED Phase PHASE4
NCT06003881 Compassionate Use of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy Status APPROVED_FOR_MARKETING Phase N/A
NCT05991388 A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE2/PHASE3
NCT05991323 Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05989126 Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS) Status COMPLETED Phase PHASE3
NCT05983068 A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05976386 Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy Adults Status COMPLETED Phase PHASE1
NCT05976373 A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants. Status COMPLETED Phase PHASE1
NCT05976360 A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants Status COMPLETED Phase PHASE1
NCT05970718 A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05961709 The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05955508 A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05929664 Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery Status SUSPENDED Phase PHASE2
NCT05923424 A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults Status COMPLETED Phase PHASE1
NCT05906706 Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid Status APPROVED_FOR_MARKETING Phase N/A
NCT05878288 Deep sequencIng in Cutaneous Squamous CEll caRciNomas Status ACTIVE_NOT_RECRUITING Phase PHASE2